July 03, 2025

Celiac, Thyroid Diseases Linked to Diabetes Risk

A large US-based study found that people with celiac disease, hyperthyroidism, or hypothyroidism face a two- to threefold increased risk of developing type 1 diabetes, with the highest risk seen in children.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 25, 2025

Combo Obesity Therapy Preserves Muscle, Reduces Fat

A new combination therapy of semaglutide and bimagrumab helped patients lose more fat while preserving muscle mass, while a novel biosensor may help track muscle loss during obesity treatment.

Conexiant

June 19, 2025

GLP-1 Use Associated with Less Pain, Fatigue

At the EULAR 2025 Congress, researchers reported that GLP-1 receptor agonists were linked to reduced opioid use, pain, and fatigue in fibromyalgia patients based on a large real-world analysis.

Conexiant

June 06, 2025

Dry Eye Tests May Aid in Diagnosing Thyroid Disorders

An evaluation of NIBUT and MG may aid in diagnosing thyroid disorders.

Optometric Management

May 09, 2024

Time of Day May Impact Aging Predictions

New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.

Conexiant

June 05, 2024

Body Roundness Index Predicts Mortality: Key Risks Revealed

A recent study found that extreme Body Roundness Index levels significantly increase the risk of all-cause mortality among US adults, highlighting the importance of this measure in health assessments.

Conexiant

February 07, 2025

Is Thyroid Cancer Overdiagnosed?

A retrospective study provides new evidence that thyroid cancer continues to be overdiagnosed and that aggressive screening and treatment of thyroid cancer has not led to higher survival rates.

The ASCO Post

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant